NeuroBo Pharmaceuticals, Inc
Why Robinhood?
You can watch NRBO and buy or sell other stocks, ETFs, and their options commission-free!About NRBO
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
NRBO Key Statistics
Stock Snapshot
As of today, NeuroBo Pharmaceuticals, Inc(NRBO) shares are valued at $8.18. The company's market cap stands at 18.89M, with a P/E ratio of -0.14.
On 2026-04-02, NeuroBo Pharmaceuticals, Inc(NRBO) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for NeuroBo Pharmaceuticals, Inc(NRBO) stock has reached 0, versus its average volume of 139.95K.
Over the past 52 weeks, NeuroBo Pharmaceuticals, Inc(NRBO) stock has traded between a high of $23.10 and a low of $1.17.
Over the past 52 weeks, NeuroBo Pharmaceuticals, Inc(NRBO) stock has traded between a high of $23.10 and a low of $1.17.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.